Chimeric Therapeutics (ASX: CHM) Share Price

CHM

$0.075▼-1.32%

$3.1MRank #1772 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$3.1M

Volume

235K

P/E Ratio

-0.15

EPS

-$0.3442

Dividend Yield

0.00%

52-Week High

$0.60

52-Week Low

$0.075

Beta

0.731

Chimeric Therapeutics (ASX: CHM) is an Australian-listed company in the Healthcare sector with a market capitalisation of $3.1M and the 1772nd-largest security on the ASX by market capitalisation. The CHM share price is $0.075, down 1.32% today and up 1775.00% over the past 12 months. Shares have traded between $0.075 and $0.60 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Chimeric Therapeutics reported revenue of $0 and a net loss of $11.2M.

Charts

$0.07

24H Range

$0.075

$0.077

52-Week Range

$0.075

$0.60

About Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical firm dedicated to developing and commercializing a diverse array of cell therapies designed to combat various cancers. Its lead natural killer (NK) cell platform, CHM 0201, is currently undergoing Phase I clinical evaluation for both solid tumors and hematological malignancies. Another key candidate, CHM 1101 (a CLTX CAR T therapy), is also in Phase I trials, specifically targeting recurrent or progressive glioblastoma in patients expressing MMP2+. Beyond these, the company's development pipeline encompasses CHM 0301 for blood cancers; CLTX CAR NK (CHM 1301) and CDH17 CAR NK (CHM 2301) for solid tumors. The CLTX CAR T platform (CHM 1101) is additionally being investigated for melanoma, colorectal, and prostate cancers, while CDH17 CAR T (CHM 2101) is being developed for neuroendocrine, colorectal, pancreatic, and gastric cancers. Chimeric Therapeutics, headquartered in Carlton, Australia, was founded in 2020.

IPO Date

17 Jan 2021

CEO

Rebecca McQualter

Website

chimerictherapeutics.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-11.2M
Total Assets	$5.9M
Total Debt	$0
Free Cash Flow	$-3.8M
Return on Equity	370.27%
Profit Margin	—
Operating Margin	—

CHM Frequently Asked Questions

What is the Chimeric Therapeutics (ASX: CHM) share price?

The CHM share price is $0.075, down 1.32% for the day, based on the latest available ASX market data.

What is Chimeric Therapeutics's market capitalisation?

Chimeric Therapeutics has a market capitalisation of $3.1M, making it the 1772nd-largest security listed on the ASX.

Does Chimeric Therapeutics pay a dividend?

CHM does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Chimeric Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), CHM reported revenue of $0 and a net loss of $11.2M.

How many CHM shares are on issue?

Chimeric Therapeutics has approximately 41,043,093 shares on issue, based on its market capitalisation of $3.1M and current share price.

What sector is Chimeric Therapeutics in?

Chimeric Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Chimeric Therapeutics list on the ASX?

Chimeric Therapeutics listed on the Australian Securities Exchange on 17 Jan 2021.

Latest News

ALERT: Price-sensitive ASX Announcement for CHM

intelligentinvestor.com.au19 Dec 2025

ALERT: Price-sensitive ASX Announcement for CHM intelligentinvestor.com.au

Chimeric Therapeutics reports strong early results from CHM CDH17 Phase 1/2 trial

BiotechDispatch13 Nov 2025

Chimeric Therapeutics reports strong early results from CHM CDH17 Phase 1/2 trial BiotechDispatch

Top 10 at 11: Chimeric has complete response in 60pc of leukemia cohort; market slides on open

Stockhead27 Apr 2026

Top 10 at 11: Chimeric has complete response in 60pc of leukemia cohort; market slides on open Stockhead

Chimeric Therapeutics Secures $8.4 Million Funding to Advance CHM CDH17 Program

Sharecafe23 Dec 2025

Chimeric Therapeutics Secures $8.4 Million Funding to Advance CHM CDH17 Program Sharecafe

Are Chimeric Therapeutics (ASX:CHM) Leading ASX 200?

Kalkine Media27 Apr 2026

Are Chimeric Therapeutics (ASX:CHM) Leading ASX 200? Kalkine Media

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
MEMMemphasys Limited	$17.1M	$0.006	-1.59	0.00%	–+0.00%
IXCInvex Therapeutics Ltd	$9.0M	$0.12	-3.15	0.00%	▲+31.87%
ACRAcrux Limited	$6.8M	$0.017	9.33	0.00%	▼-5.56%
ECSECS Botanics Holdings Ltd	$6.5M	$0.005	-2.57	0.00%	–+0.00%
BGTBio-Gene Technology Limited	$5.9M	$0.022	-1.25	0.00%	▲+10.00%
HIQHITIQ Limited	$5.0M	$0.01	-0.96	0.00%	–+0.00%
PERPercheron Therapeutics Limited	$4.5M	$0.004	-0.79	0.00%	▼-11.11%
BITBiotron Limited	$3.3M	$0.002	-1.22	0.00%	–+0.00%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.077	$0.077	$0.075	$0.075	225K	▼-1.32%
11 June 2026	$0.079	$0.079	$0.076	$0.076	141K	▼-5.00%
10 June 2026	$0.082	$0.082	$0.08	$0.08	90K	▼-9.09%
9 June 2026	$0.085	$0.088	$0.085	$0.088	0	▲+7.32%
8 June 2026	$0.09	$0.09	$0.082	$0.082	206K	–+0.00%
5 June 2026	$0.09	$0.09	$0.082	$0.082	191K	▼-8.89%
4 June 2026	$0.092	$0.092	$0.083	$0.09	414K	▼-2.17%
3 June 2026	$0.10	$0.10	$0.092	$0.092	377K	▼-8.00%
2 June 2026	$0.11	$0.11	$0.10	$0.10	188K	▼-9.09%
1 June 2026	$0.10	$0.135	$0.10	$0.11	652K	▲+10.00%
29 May 2026	$0.10	$0.105	$0.10	$0.10	28K	–+0.00%
28 May 2026	$0.105	$0.105	$0.10	$0.10	87K	▼-9.09%
27 May 2026	$0.12	$0.12	$0.10	$0.11	509K	▼-8.33%
26 May 2026	$0.13	$0.13	$0.12	$0.12	133K	▼-7.69%
25 May 2026	$0.13	$0.13	$0.13	$0.13	8K	–+0.00%
22 May 2026	$0.125	$0.13	$0.12	$0.13	110K	–+0.00%
21 May 2026	$0.125	$0.13	$0.125	$0.13	258K	–+0.00%
20 May 2026	$0.125	$0.13	$0.125	$0.13	102K	▲+4.00%
19 May 2026	$0.125	$0.125	$0.125	$0.125	600	▼-3.85%
18 May 2026	$0.13	$0.13	$0.125	$0.13	179K	–+0.00%
15 May 2026	$0.14	$0.14	$0.13	$0.13	140K	▼-3.70%
14 May 2026	$0.14	$0.14	$0.135	$0.135	100K	▲+3.85%
13 May 2026	$0.135	$0.145	$0.13	$0.13	100K	▼-3.70%
12 May 2026	$0.14	$0.14	$0.135	$0.135	149K	–+0.00%
11 May 2026	$0.155	$0.155	$0.13	$0.135	114K	–+0.00%
8 May 2026	$0.145	$0.145	$0.135	$0.135	260K	▼-6.90%
7 May 2026	$0.145	$0.145	$0.145	$0.145	171K	▼-3.33%
6 May 2026	$0.16	$0.16	$0.145	$0.15	166K	▲+3.45%
5 May 2026	$0.16	$0.16	$0.145	$0.145	205K	▼-12.12%
4 May 2026	$0.165	$0.165	$0.155	$0.165	429K	▼-2.94%

About Chimeric Therapeutics Limited

IPO Date

17 Jan 2021

CEO

Rebecca McQualter

Website

chimerictherapeutics.com

CHM Frequently Asked Questions

What is the Chimeric Therapeutics (ASX: CHM) share price?

The CHM share price is $0.075, down 1.32% for the day, based on the latest available ASX market data.

What is Chimeric Therapeutics's market capitalisation?

Chimeric Therapeutics has a market capitalisation of $3.1M, making it the 1772nd-largest security listed on the ASX.

Does Chimeric Therapeutics pay a dividend?

CHM does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Chimeric Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), CHM reported revenue of $0 and a net loss of $11.2M.

How many CHM shares are on issue?

Chimeric Therapeutics has approximately 41,043,093 shares on issue, based on its market capitalisation of $3.1M and current share price.

What sector is Chimeric Therapeutics in?

Chimeric Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Chimeric Therapeutics list on the ASX?

Chimeric Therapeutics listed on the Australian Securities Exchange on 17 Jan 2021.

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
MEMMemphasys Limited	$17.1M	$0.006	-1.59	0.00%	–+0.00%
IXCInvex Therapeutics Ltd	$9.0M	$0.12	-3.15	0.00%	▲+31.87%
ACRAcrux Limited	$6.8M	$0.017	9.33	0.00%	▼-5.56%
ECSECS Botanics Holdings Ltd	$6.5M	$0.005	-2.57	0.00%	–+0.00%
BGTBio-Gene Technology Limited	$5.9M	$0.022	-1.25	0.00%	▲+10.00%
HIQHITIQ Limited	$5.0M	$0.01	-0.96	0.00%	–+0.00%
PERPercheron Therapeutics Limited	$4.5M	$0.004	-0.79	0.00%	▼-11.11%
BITBiotron Limited	$3.3M	$0.002	-1.22	0.00%	–+0.00%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.077	$0.077	$0.075	$0.075	225K	▼-1.32%
11 June 2026	$0.079	$0.079	$0.076	$0.076	141K	▼-5.00%
10 June 2026	$0.082	$0.082	$0.08	$0.08	90K	▼-9.09%
9 June 2026	$0.085	$0.088	$0.085	$0.088	0	▲+7.32%
8 June 2026	$0.09	$0.09	$0.082	$0.082	206K	–+0.00%
5 June 2026	$0.09	$0.09	$0.082	$0.082	191K	▼-8.89%
4 June 2026	$0.092	$0.092	$0.083	$0.09	414K	▼-2.17%
3 June 2026	$0.10	$0.10	$0.092	$0.092	377K	▼-8.00%
2 June 2026	$0.11	$0.11	$0.10	$0.10	188K	▼-9.09%
1 June 2026	$0.10	$0.135	$0.10	$0.11	652K	▲+10.00%
29 May 2026	$0.10	$0.105	$0.10	$0.10	28K	–+0.00%
28 May 2026	$0.105	$0.105	$0.10	$0.10	87K	▼-9.09%
27 May 2026	$0.12	$0.12	$0.10	$0.11	509K	▼-8.33%
26 May 2026	$0.13	$0.13	$0.12	$0.12	133K	▼-7.69%
25 May 2026	$0.13	$0.13	$0.13	$0.13	8K	–+0.00%
22 May 2026	$0.125	$0.13	$0.12	$0.13	110K	–+0.00%
21 May 2026	$0.125	$0.13	$0.125	$0.13	258K	–+0.00%
20 May 2026	$0.125	$0.13	$0.125	$0.13	102K	▲+4.00%
19 May 2026	$0.125	$0.125	$0.125	$0.125	600	▼-3.85%
18 May 2026	$0.13	$0.13	$0.125	$0.13	179K	–+0.00%
15 May 2026	$0.14	$0.14	$0.13	$0.13	140K	▼-3.70%
14 May 2026	$0.14	$0.14	$0.135	$0.135	100K	▲+3.85%
13 May 2026	$0.135	$0.145	$0.13	$0.13	100K	▼-3.70%
12 May 2026	$0.14	$0.14	$0.135	$0.135	149K	–+0.00%
11 May 2026	$0.155	$0.155	$0.13	$0.135	114K	–+0.00%
8 May 2026	$0.145	$0.145	$0.135	$0.135	260K	▼-6.90%
7 May 2026	$0.145	$0.145	$0.145	$0.145	171K	▼-3.33%
6 May 2026	$0.16	$0.16	$0.145	$0.15	166K	▲+3.45%
5 May 2026	$0.16	$0.16	$0.145	$0.145	205K	▼-12.12%
4 May 2026	$0.165	$0.165	$0.155	$0.165	429K	▼-2.94%